Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein Doppler waveform.

Hussain Q, Haider S, Solangi NM, Ali L, Liaquat H, Ahmed F, Shahbaz S.

J Pak Med Assoc. 2013 May;63(5):604-8.

2.

Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response.

Baik SK, Kim JW, Kim HS, Kwon SO, Kim YJ, Park JW, Kim SH, Chang SJ, Lee DK, Han KH, Um SH, Lee SS.

Radiology. 2006 Aug;240(2):574-80.

PMID:
16864678
3.

[Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].

Jeong PH, Baik SK, Choi YJ, Park DH, Kim MY, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Kim ND.

Taehan Kan Hakhoe Chi. 2002 Sep;8(3):264-70. Korean.

4.

Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.

Kim MY, Baik SK, Park DH, Lim DW, Kim JW, Kim HS, Kwon SO, Kim YJ, Chang SJ, Lee SS.

Liver Int. 2007 Oct;27(8):1103-10.

PMID:
17845539
5.

Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.

Choi YJ, Baik SK, Park DH, Kim MY, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW.

J Gastroenterol Hepatol. 2003 Apr;18(4):424-9.

PMID:
12653891
6.

Effect of carvedilol on portal pressure estimated by hepatic vein Doppler ultrasound waveform and damping index in cirrhotic patients.

Hussain Q, Badruddin AH, Chaudhry MA, Ahmad F, Abbasi A.

J Coll Physicians Surg Pak. 2010 Sep;20(9):586-9. doi: 09.2010/JCPSP.586589.

PMID:
20810049
7.

Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.

Narahara Y, Kanazawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Kidokoro H, Harimoto H, Fukuda T, Matsushita Y, Nakatsuka K, Sakamoto C.

J Gastroenterol Hepatol. 2009 Nov;24(11):1791-7. doi: 10.1111/j.1440-1746.2009.05873.x.

PMID:
19686420
8.

Doppler waveform study as indicator of change of portal pressure after administration of octreotide.

Haider S, Hussain Q, Tabassum S, Hussain B, Durrani MR, Ahmed F.

Pak J Med Sci. 2016 Jul-Aug;32(4):935-8. doi: 10.12669/pjms.324.10275.

10.

Hepatic vein waveform in liver cirrhosis: correlation with child's class and size of varices.

Bhutto AR, Abbasi A, Butt N, Khan A, Munir SM.

J Pak Med Assoc. 2012 Aug;62(8):794-7.

11.

Time profile of the haemodynamic effects of terlipressin in portal hypertension.

Escorsell A, Bandi JC, Moitinho E, Feu F, García-Pagan JC, Bosch J, Rodés J.

J Hepatol. 1997 Mar;26(3):621-7.

PMID:
9075670
12.

Prognostic significance of hepatic vein waveform by Doppler ultrasonography in cirrhotic patients with portal hypertension.

Ohta M, Hashizume M, Kawanaka H, Akazawa K, Tomikawa M, Higashi H, Kishihara F, Tanoue K, Sugimachi K.

Am J Gastroenterol. 1995 Oct;90(10):1853-7.

PMID:
7572908
13.

Analysis of hepatic vein waveform by Doppler ultrasonography in 100 patients with portal hypertension.

Ohta M, Hashizume M, Tomikawa M, Ueno K, Tanoue K, Sugimachi K.

Am J Gastroenterol. 1994 Feb;89(2):170-5.

PMID:
8304297
14.
15.

Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.

Lee WC, Lin HC, Yang YY, Hou MC, Lee FY, Chang FY, Lee SD.

Am J Gastroenterol. 2001 Apr;96(4):1210-6.

PMID:
11316172
17.

Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implications.

Kawanaka H, Kinjo N, Anegawa G, Yoshida D, Migoh S, Konishi K, Ohta M, Yamaguchi S, Tomikawa M, Hashizume M, Maehara Y.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e129-36.

PMID:
17924952
18.

Qualitative hepatic venous Doppler sonography versus portal flowmetry in predicting the severity of esophageal varices in hepatitis C cirrhosis.

Gorka W, al Mulla A, al Sebayel M, Altraif I, Gorka TS.

AJR Am J Roentgenol. 1997 Aug;169(2):511-5.

PMID:
9242766
19.

Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.

Lin HC, Yang YY, Hou MC, Huang YT, Lee WC, Lee FY, Chang FY, Lee SD.

Scand J Gastroenterol. 2002 Apr;37(4):482-7.

PMID:
11989841
20.

Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.

Kalambokis G, Economou M, Paraskevi K, Konstantinos P, Pappas C, Katsaraki A, Tsianos EV.

J Gastroenterol Hepatol. 2005 Jul;20(7):1075-81.

PMID:
15955217
Items per page

Supplemental Content

Support Center